Table 1 Participants’ sociodemographic characteristics and clinical scores (N = 88).

From: Relationship between behavioral and mood responses to monetary rewards in a sample of Indian students with and without reported pain

 

Sub-clinical Group

(N = 40)

Control group

(N = 48)

Statistics

      

N (%)

N (%)

Test value

Significance (p)

Gender

   

0.91

      

Female

20 (51.3%)

22(50%)

χ2 = 0.14

       

Male

19(48.7%)

22(50%)

      

Language

   

0.189

      

English

35 (89.7%)

30 (75%)

t(79)=2.35

       

Other

4(10.3%)

10 (25%)

      
 

Mean (SD)

Mean (SD)

        

Age

21.32 (2.31)

22.25(2.33)

t(81)=1.81

0.074

      

Psychometric measures

Mean

SD

Min

Max

Mean

SD

Min

Max

  

HADS (anxiety)

9.45

4.43

0

17

8.66

4.30

0

17

t(81)=1.98

0.052

HADS (depression)

7.25

3.64

0

15

5.97

3.62

0

17

t(81)=1.96

0.053

SCL-27-plus-socio-phobic symptoms

2.49

1.01

0

4

2.00

1.09

0

4

t(81)=1.56

0.122

SCL-27-plus-vegetative symptoms

2.00

0.89

0

3.80

1.99

0.88

0

3.20

t(81)=1.78

0.078

SCL-27-plus-agoraphobic symptoms

1.32

0.91

0

3.25

1.00

0.91

0

2.75

t(81)=1.51

0.135

SCL-27-plus-depressive symptoms

2.09

1.001

0

4

1.98

1.01

0

4

t(81)=1.48

0.142

SCL-27-plus-pain symptoms

2.31

0.47

1.33

4

1.00

0.59

0

3

t(81) = 11.05

 < 0.01

Headaches

2.87

0.61

2

4

1.70

1.37

0

4

  

Chest pains

1.84

1.40

0

4

0.55

1.20

0

4

Muscle cramps

2.56

0.85

0

4

1.11

1.33

0

4

Muscle pain/sore muscles

2.76

0.77

0

4

1.09

1.37

0

4

Pain in arms or legs

1.84

1.11

0

4

0.84

0.99

0

4

Backaches

1.97

1.03

0

4

0.70

0.85

0

4

SCL-27-plus-lifetime assessment for depressive symptoms

1.41

0.39

1

2

1.51

0.35

1

2

t(73)=-0.85

0.398

  1. This table demonstrates participants’ sociodemographic characteristics and the clinical scores of both groups on different psychometric measures used in the study.
  2. SCL-27-plus Symptom Checklist, HADS Hospital Anxiety and Depression Scale, Sub-Clinical Group participants with clinically significant pain symptoms, Control Group participants without clinically significant pain symptoms.
Back to article page